Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incorporation of Child & Adolescent Mental Health Standardized Patient Simulations to Provide Interprofessional Education for Graduate Students.

Issues in mental health nursing·2022

Same author

Evaluating the Usability of a Second-Generation Virtual Reality Game for Refreshing Sterile Urinary Catheterization Skills.

Nurse educator·2019

Same author

Reliability and Validity of NCLEX-RN© State Pass Rate Standards.

Nursing education perspectives·2018

Same author

Hip Fractures.

Advanced emergency nursing journal·2018

Same author

The accuracy of state NCLEX-RN© passing standards for nursing programs.

Nurse education today·2017

Same author

Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.

The Diabetes educator·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Using insulin pump therapy in poorly controlled type 2 diabetes.

Phyllis Wolff-McDonagh¹, Judith Kaufmann¹, Stephen Foreman¹

¹The Graduate School of Nursing, Robert Morris University, Moon Township, Pennsylvania

The Diabetes Educator

|June 24, 2010

Summary

Continuous subcutaneous insulin infusion (CSII) improved glycemic control in type 2 diabetes patients. This insulin pump method significantly reduced basal insulin needs and showed cost-effectiveness for some, warranting policy re-evaluation.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Related Experiment Videos

Last Updated: Jun 12, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Area of Science:

Endocrinology
Metabolic Diseases
Pharmacology

Background:

Type 2 diabetes (T2D) management often involves complex insulin regimens.
Poorly controlled T2D necessitates exploring advanced therapeutic options like insulin pumps.
Continuous subcutaneous insulin infusion (CSII) is an alternative insulin delivery method.

Purpose of the Study:

To assess insulin regimens in poorly controlled type 2 diabetes.
To evaluate the feasibility of insulin pumps (CSII) in T2D patients.
To gather evidence on CSII effectiveness for T2D.

Main Methods:

Pilot study in a suburban endocrinology practice.
15 adults (40-64 years) with hemoglobin A1C (A1C) ≥ 8% initiated CSII.
Data collected: A1C, BMI, insulin use, office visits; analyzed with descriptive and t tests.

Main Results:

Significant reduction in basal insulin requirements.
Sustained significant reductions in A1C levels at 3, 6, and 12 months.
Noted a significant increase in body mass index (BMI).

Conclusions:

CSII improved glycemic control in some T2D patients, with an associated BMI increase.
Significant reduction in basal insulin use and potential cost-effectiveness with CSII.
Current policies on CSII for T2D require re-evaluation based on these findings.